Historical record - last NADAC publication: 2/18/2015
Product Information
QC FIBERLAX 625 MG CAPLET is a generic product labeled by Chain Drug Marketing Association, priced at $0.0525 per EA under NDC 63868053090. Its NADAC has been published 67 times since Nov 28, 2013.
The Low Outlier badge above means this manufacturer's average price in the Calcium Polycarbophil market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
625 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868053090
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
2/18/2015
Active Ingredients
CALCIUM POLYCARBOPHILApproval Type
OTC MONOGRAPH DRUG
FDA Application
M007On Market Since
4/16/2019
Price Statistics
The NADAC for QC FIBERLAX 625 MG CAPLET has been published 67 times since Nov 28, 2013, and over the history we have for it it has declined 3.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0525 per EA |
|---|---|
| All-time high | $0.0613 (Sep 10, 2014) |
| All-time low | $0.0525 (Feb 18, 2015) |
| Median price | $0.0566 |
| Average price | $0.0567 |
| Largest weekly change | -7.2% (Feb 18, 2015) |
| Weeks tracked | 67 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC FIBERLAX 625 MG CAPLET?
The current National Average Drug Acquisition Cost (NADAC) for QC FIBERLAX 625 MG CAPLET, manufactured by Chain Drug Marketing Association, is $0.0525 per EA (NDC 63868053090), effective Mar 4, 2015.
How has the price of QC FIBERLAX 625 MG CAPLET changed over time?
Over the history we have for it, the NADAC for QC FIBERLAX 625 MG CAPLET has declined 3.0%. It has been tracked across 67 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QC FIBERLAX 625 MG CAPLET?
Since Nov 28, 2013, the NADAC for QC FIBERLAX 625 MG CAPLET has ranged from a low of $0.0525 (Feb 18, 2015) to a high of $0.0613 (Sep 10, 2014), with a median of $0.0566 per EA.
Are there cheaper alternatives to QC FIBERLAX 625 MG CAPLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as QC FIBERLAX 625 MG CAPLET, but none are currently priced below it.
Who manufactures QC FIBERLAX 625 MG CAPLET?
QC FIBERLAX 625 MG CAPLET (NDC 63868053090) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification